keyword
MENU ▼
Read by QxMD icon Read
search

Roxanol

keyword
https://www.readbyqxmd.com/read/8591836/fatal-morphine-poisoning-in-a-child-due-to-accidental-oral-ingestion
#1
A Poklis, L E Edinboro, A S Wohler, F Presswalla, D Barron
A case of fatal intoxication of an 8 year old child due to accidental oral ingestion of morphine is presented. Following a tonsillectomy and release from the hospital the decedent was prescribed meperidine syrup 50 mg per teaspoon (tsp) to be taken 2 tsps every 4 h. A pharmacist when filling her prescription mistakenly dispensed Roxanol which contained 20 mg/ml morphine sulfate. She took 1 or 2 tsp of the prescription prior to bed and was found dead the next morning. Autopsy findings were unremarkable. Quantitation by gas chromatography/mass spectrometry (GC/MS) yielded the following morphine results: blood, 0...
November 30, 1995: Forensic Science International
https://www.readbyqxmd.com/read/8487059/placebo-blinded-study-of-morphine-sulfate-sustained-release-tablets-and-immediate-release-morphine-sulfate-solution-in-outpatients-with-chronic-pain-due-to-advanced-cancer
#2
RANDOMIZED CONTROLLED TRIAL
J W Finn, T D Walsh, N MacDonald, E Bruera, L U Krebs, K V Shepard
PURPOSE: This study was conducted to compare the relative analgesic efficacy and safety of an every-4-hour immediate-release oral morphine (IRM) solution with that of an every-12-hour sustained-release oral morphine (SRM) formulation. PATIENTS AND METHODS: This was a double-blind, placebo-blinded, crossover study in 34 adult male and female outpatients with pain due to advanced cancer. Baseline data were collected on day 1. On days 2 and 3, randomly assigned patients received either placebo plus IRM (Roxanol; Roxane Laboratories, Inc, Columbus, OH; 20 mg/mL) at 2, 6, and 10 am, and 2, 6, and 10 pm, or alternatively SRM (Oramorph SR; Roxane Laboratories, Inc; 30 mg) at 10 AM and 10 PM...
May 1993: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
https://www.readbyqxmd.com/read/8038464/compatibility-of-oral-morphine-sulfate-solution-with-enteral-feeding-products
#3
COMPARATIVE STUDY
G O Udeani, J Bass, T P Johnston
OBJECTIVE: Patients with terminal cancer often receive continuous enteral nutrition and oral medications concomitantly through nasogastric or gastrostomy feeding tubes. This study evaluated in vitro the compatibility of morphine sulfate (MS) solution 2 mg/mL (Roxane Laboratories) with three enteral nutrition products (Jevity [J], Osmolite-HN [O], and Pulmocare [P]) at 22 and 37 degrees C for 48 hours and J alone at 50 degrees C for 48 hours. METHODS: Mixtures containing 1 mg/mL MS were prepared with each enteral product: J, O, and P (Ross Laboratories)...
April 1994: Annals of Pharmacotherapy
https://www.readbyqxmd.com/read/3659062/the-use-of-sustained-release-morphine-in-a-hospice-setting
#4
L M Sherman
Thirty-seven patients with advanced cancer requiring oral administration of strong narcotics for pain control have been treated with one or other of two commercially-available, sustained-release morphine preparations. Patients were followed up primarily at home, supervised by a local hospice care team, and received daily dosage ranging from 60 mg to 420 mg morphine administered as 30 mg sustained-release tablets delivered at intervals from 6 to 10 hours for 'Roxanol SR' and from 8 to 14 hours for 'MS Contin'...
1987: Pharmatherapeutica
https://www.readbyqxmd.com/read/1934000/comparison-of-the-pharmacokinetic-profiles-of-two-oral-controlled-release-morphine-formulations-in-healthy-young-adults
#5
COMPARATIVE STUDY
T L Hunt, R F Kaiko
The pharmacokinetic profiles of two oral controlled-release morphine formulations, MS Contin tablets and Roxanol SR tablets, were compared to evaluate their bioequivalence. In a sequential, crossover study, 18 healthy young male volunteers received single 60-mg doses (two 30-mg tablets) of each formulation and provided 15 serial blood samples over 24 hours, which were assayed to determine their morphine concentrations by high-performance liquid chromatography. Analysis of variance revealed significant differences between the treatments for maximum plasma concentration (P less than 0...
July 1991: Clinical Therapeutics
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"